June 3, 2016

State of Alabama
Press Release: Medicaid

PDL Quarterly Update

PDF Version


TO:   Pharmacies, Physicians, Physicians Assistants, Nurse Practitioners, Oral Surgeons,  Optometrists, Dentists, FQHCs, RHCs, Mental Health Service Providers, and Nursing Homes                    

 

RE:    PDL Quarterly Update

 

Effective July 1, 2016, the Alabama Medicaid Agency will:

1.    Include the Disease-Modifying Antirheumatic Drugs (DMARDs) in the
      Preferred Drug List (PDL).

 

2.        Implement a “Preferred with Clinical Criteria” program. For select drug classes, Alabama Medicaid will require clinical criteria be submitted for preferred products on the PDL. Preferred products will require a prior authorization request be submitted. Clinical criteria must be met in order to be approved.  Non-preferred products will continue to require prior authorization; for a non-preferred product to be approved, failure with a designated number of preferred agents and clinical criteria must be met.  Alabama Medicaid will begin with the following classes:

·   DMARDS

·   Hepatitis C Antivirals

 

3.     Require prior authorization (PA) for payment of all methadone products

         (including generics).

 

4.     Update the PDL to reflect the quarterly updates.

The updates are listed below:  PDL Additions

Kitabis

Aminoglycosides

guanfacine ER

Cerebral Stimulants/ADHD

Cimziacc

Disease-modifying Antirheumatic Agents

Enbrelcc

Disease-modifying Antirheumatic Agents

Humiracc

Disease-modifying Antirheumatic Agents

Toviaz

Genitourinary Smooth Muscle Relaxants

Harvonicc

HCV Antivirals

Techniviecc

HCV Antivirals

Viekira Pakcc

HCV Antivirals

PDL Deletions

Intuniv

Cerebral Stimulants/ADHD

alogliptin

DPP-4 Inhibitors

alogliptin/metformin

DPP-4 Inhibitors

alogliptin/pioglitazone

DPP-4 Inhibitors

Kombiglyze

DPP-4 Inhibitors

Onglyza

DPP-4 Inhibitors

Tradjenta

DPP-4 Inhibitors

Jentadueto

DPP-4 Inhibitors

methadone

Opiate Agonists

Ventolin HFA*

Respiratory Beta-adrenergic Agonists

                         cc Preferred with Clinical Criteria
                     * Product was temporarily preferred due to shortage of preferred agents

 

For additional PDL and coverage information, visit our drug look-up site at https://www.medicaid.alabamaservices.org/ALPortal/NDC%20Look%20Up/tabId/39/Default.aspx.

The PA request form and criteria booklet, as well as a link for a PA request form that can be completed and submitted electronically online, can be found on the Agency’s website at www.medicaid.alabama.gov and should be utilized by the prescriber or the dispensing pharmacy when requesting a PA. Providers requesting PAs by mail or fax should send requests to:

Health Information Designs (HID)

Medicaid Pharmacy Administrative Services

P. O. Box 3210 Auburn, AL 36832-3210

Fax: 1-800-748-0116

Phone: 1-800-748-0130

Incomplete PA requests or those failing to meet Medicaid criteria will be denied. If the prescriber believes medical justification should be considered, the prescriber must document this on the form or submit a written letter of medical justification along with the PA form to HID. Additional information may be requested. Staff physicians will review this information.

 

Policy questions concerning this provider notice should be directed to the Pharmacy Program at (334) 242-5050. Questions regarding PA procedures should be directed to the HID help desk at 1-800-748-0130.

 




  • For more information, visit http://medicaid.alabama.gov
  • For more state-wide press releases, click here